BNP Paribas set a €116.00 ($138.10) price objective on Merck KGaA (FRA:MRK) in a research note issued to investors on Wednesday morning. The firm currently has a buy rating on the healthcare company’s stock.

Other analysts have also issued reports about the stock. equinet AG set a €91.00 ($108.33) price target on shares of Merck KGaA and gave the stock a neutral rating in a research report on Saturday, May 20th. DZ Bank AG restated a neutral rating on shares of Merck KGaA in a research report on Saturday, May 20th. Warburg Research set a €116.00 ($138.10) price target on shares of Merck KGaA and gave the stock a neutral rating in a research report on Tuesday, June 20th. J P Morgan Chase & Co restated a neutral rating on shares of Merck KGaA in a research report on Friday, August 4th. Finally, Deutsche Bank AG set a €106.00 ($126.19) price target on shares of Merck KGaA and gave the stock a neutral rating in a research report on Friday, August 4th. Fourteen investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The stock presently has an average rating of Hold and an average price target of €107.71 ($128.23).

Shares of Merck KGaA (FRA:MRK) opened at 95.623 on Wednesday. The firm has a market cap of €41.57 billion and a price-to-earnings ratio of 24.928. Merck KGaA has a 52 week low of €89.00 and a 52 week high of €115.00. The stock has a 50 day moving average of €93.50 and a 200-day moving average of €102.64.

TRADEMARK VIOLATION WARNING: This report was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/09/09/bnp-paribas-analysts-give-merck-kgaa-mrk-a-116-00-price-target.html.

Merck KGaA Company Profile

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.